Please Wait.....
Report
Ventilators - Company Evaluation Report, 2024
Market Report I 2025-05-01 I 121 Pages I MarketsandMarkets
The Ventilator Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for ventilators. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and industry trends. MarketsandMarkets 360 Quadrants evaluated over 140 companies, of which the Top 21 ventilator Companies were categorized and recognized as the quadrant leaders.
The ventilators market has seen significant evolution driven by technological advancements, including the development of advanced portable ventilators and enhanced sensor technologies. Key factors fueling market growth include the rising number of preterm births, the rapidly aging global population, the increasing prevalence of respiratory illnesses, and a growing preference for home-based oxygen therapy. Additionally, outbreaks of infectious respiratory diseases have further accelerated demand. The expansion of home healthcare services has opened new avenues for market growth. However, challenges such as a shortage of skilled medical personnel and the over-purchasing of ventilators may hinder market expansion to some extent.
The 360 Quadrant maps the ventilator companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the ventilator quadrant. The top criteria for product footprint evaluation included Type (Intensive care and portable/transportable ventilators), Age Group (Adult & pediatric ventilators (above two years of age) and neonatal/infant ventilators (below two years of age), and Process (Invasive, non-invasive, and hybrid), Care Setting(Hospitals & clinics, home care settings, ambulatory care centers, emergency medical services, and other care settings), Mode(volume-mode ventilators, pressure-mode ventilators, combined-mode ventilators, and other ventilator modes).
Key Players:
The ventilators market is highly diversified and competitive, with many players. Some of the prominent players in this market are Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Vyaire Medical, Inc. (US), Getinge AB (Sweden), Dragerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Hamilton Medical (Switzerland), GE Healthcare (US), Skanray Technologies, Ltd. (India), Air Liquide (France), and Asahi Kasei Corporation (Japan).
ResMed
ResMed is a leader in the ventilators market, known for its innovative product portfolio and extensive geographic presence across North America, the Asia Pacific, and Europe. The company focuses on developing new products while navigating supply chain challenges, ensuring it meets global demand. Its strategic emphasis on cloud-connected devices advances patient monitoring and strengthens its market share.
Getinge AB
Getinge AB holds a significant position in the ventilator market, attributed to its robust product portfolio catering to adult and pediatric patients. The company's focus on emerging markets and initiatives like the India Innovation Centre contribute to its success. The integration of digital health solutions and strategic partnerships further enhances its competitive edge, supporting continuous growth and demand for critical care equipment.
Koninklijke Philips N.V.
Koninklijke Philips N.V. (Philips) is prominent in the ventilators market through its subsidiary, Philips Respironics, which provides a comprehensive range of respiratory care devices. With a strong global sales and distribution network, Philips emphasizes R&D to maintain its innovative edge. Its strategic partnerships and acquisitions, such as those with SinoMed Imaging System and InSightec, have expanded its market reach, supporting its robust position in the ventilators sector.
1 INTRODUCTION 12
1.1 MARKET DEFINITION 12
1.2 STAKEHOLDERS 12
2 EXECUTIVE SUMMARY 13
3 MARKET OVERVIEW 17
3.1 INTRODUCTION 17
3.2 MARKET DYNAMICS 17
3.2.1 DRIVERS 18
3.2.1.1 Rise in respiratory diseases 18
3.2.1.1.1 Increasing incidences of COPD and asthma 18
3.2.1.1.2 High prevalence of tobacco smoking 18
3.2.1.2 Urbanization and rising pollution levels 19
3.2.1.3 Rising obesity due to sedentary lifestyles 19
3.2.1.4 Growing geriatric population worldwide 20
3.2.1.5 Increasing preference for home care settings 20
3.2.1.6 Rising number of preterm births 21
3.2.1.7 Outbreak of infectious respiratory diseases 21
3.2.2 RESTRAINTS 22
3.2.2.1 Shortage of skilled medical workers 22
3.2.2.2 Excessive purchase of ventilators during COVID-19 22
3.2.2.3 Reimbursement concerns 22
3.2.3 OPPORTUNITIES 23
3.2.3.1 Cost-efficiency of home care services 23
3.2.3.2 Growth opportunities in emerging economies 23
3.2.4 CHALLENGES 24
3.2.4.1 Low awareness and inadequate resources in emerging economies 24
3.2.4.2 Harmful effects of respiratory devices on neonates 24
3.2.4.3 Supply chain disruptions 24
3.2.4.4 Global demand fluctuations 25
3.3 INDUSTRY TRENDS 25
3.3.1 RISING DEMAND FOR ENHANCED PORTABLE VENTILATORS 26
3.3.2 MARKET CONSOLIDATION 26
3.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS 27
3.3.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATORS 27
3.4 TECHNOLOGY ANALYSIS 28
3.4.1 KEY TECHNOLOGIES 28
3.4.1.1 Sensor technologies 28
3.4.1.1.1 Flow sensors 28
3.4.1.1.2 Oxygen sensors 28
3.4.1.1.3 Pressure sensors 29
3.4.2 COMPLEMENTARY TECHNOLOGIES 29
3.4.2.1 E-nose technology 29
3.4.2.2 MEMS technology 30
3.4.2.3 Electrochemical technology 30
3.4.2.4 Paramagnetic technology 30
3.4.2.5 Wireless gas sensor technology 31
3.4.3 ADJACENT TECHNOLOGIES 31
3.4.3.1 High-flow nasal cannula (HFNC) devices 31
3.5 VALUE CHAIN ANALYSIS 31
3.6 ECOSYSTEM ANALYSIS 33
3.7 SUPPLY CHAIN ANALYSIS 34
3.8 PORTER'S FIVE FORCES ANALYSIS 36
3.8.1 THREAT OF NEW ENTRANTS 37
3.8.2 THREAT OF SUBSTITUTES 38
3.8.3 BARGAINING POWER OF SUPPLIERS 38
3.8.4 BARGAINING POWER OF BUYERS 38
3.8.5 INTENSITY OF COMPETITIVE RIVALRY 38
3.9 PATENT ANALYSIS 39
3.9.1 PATENT PUBLICATION TRENDS FOR VENTILATORS 39
3.10 KEY CONFERENCES AND EVENTS, 2023-2024 41
3.11 REIMBURSEMENT SCENARIO 42
3.12 IMPACT OF AI/GEN AI ON VENTILATORS MARKET 43
3.12.1 INTRODUCTION 43
3.12.2 FUTURE OF HEALTHCARE-BIG DATA AND AI 43
3.12.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT 44
4 COMPETITIVE LANDSCAPE 46
4.1 OVERVIEW 46
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 46
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET 46
4.3 REVENUE ANALYSIS, 2019-2023 47
4.4 MARKET SHARE ANALYSIS, 2023 48
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 50
4.5.1 STARS 50
4.5.2 EMERGING LEADERS 50
4.5.3 PERVASIVE PLAYERS 50
4.5.4 PARTICIPANTS 50
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 51
4.5.5.1 Company footprint 52
4.5.5.2 Region footprint 53
4.5.5.3 Type footprint 54
4.5.5.4 Age group footprint 55
4.5.5.5 Interface footprint 56
4.5.5.6 Mode footprint 57
4.5.5.7 Care setting footprint 58
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 59
4.6.1 PROGRESSIVE COMPANIES 59
4.6.2 RESPONSIVE COMPANIES 59
4.6.3 DYNAMIC COMPANIES 59
4.6.4 STARTING BLOCKS 59
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 61
4.6.5.1 Detailed list of key startups/SMEs 61
4.6.5.2 Competitive benchmarking of key startups/SMEs 61
4.7 VENTILATORS MARKET: R&D EXPENDITURE 62
4.8 COMPANY VALUATION & FINANCIAL METRICS 63
4.8.1 FINANCIAL METRICS 63
4.8.2 COMPANY VALUATION 63
4.9 BRAND/PRODUCT COMPARISON 64
4.10 COMPETITIVE SCENARIO 65
4.10.1 PRODUCT LAUNCHES & APPROVALS 65
4.10.2 DEALS 66
4.10.3 OTHER DEVELOPMENTS 67
5 COMPANY PROFILES 68
5.1 KEY PLAYERS 68
5.1.1 RESMED 68
5.1.1.1 Business overview 68
5.1.1.2 Products offered 69
5.1.1.3 Recent developments 70
5.1.1.3.1 Product launches 70
5.1.1.4 MnM view 70
5.1.1.4.1 Right to win 70
5.1.1.4.2 Strategic choices 70
5.1.1.4.3 Weaknesses and competitive threats 70
5.1.2 GETINGE AB 71
5.1.2.1 Business overview 71
5.1.2.2 Products offered 72
5.1.2.3 Recent developments 73
5.1.2.3.1 Product approvals 73
5.1.2.3.2 Other developments 73
?
5.1.2.4 MnM view 73
5.1.2.4.1 Right to win 73
5.1.2.4.2 Strategic choices 74
5.1.2.4.3 Weaknesses and competitive threats 74
5.1.3 KONINKLIJKE PHILIPS N.V. 75
5.1.3.1 Business overview 75
5.1.3.2 Products offered 76
5.1.3.3 Recent developments 77
5.1.3.3.1 Other developments 77
5.1.3.4 MnM view 77
5.1.3.4.1 Right to win 77
5.1.3.4.2 Strategic choices 77
5.1.3.4.3 Weaknesses and competitive threats 77
5.1.4 DRAGERWERK AG & CO. KGAA 78
5.1.4.1 Business overview 78
5.1.4.2 Products offered 79
5.1.4.3 Recent developments 79
5.1.4.3.1 Product launches 79
5.1.4.3.2 Deals 80
5.1.4.3.3 Other developments 80
5.1.5 ICU MEDICAL INC. 81
5.1.5.1 Business overview 81
5.1.5.2 Products offered 82
5.1.5.3 Recent developments 83
5.1.5.3.1 Deals 83
5.1.6 ASAHI KASEI CORPORATION 84
5.1.6.1 Business overview 84
5.1.6.2 Products offered 85
5.1.6.3 Recent developments 86
5.1.6.3.1 Deals 86
5.1.7 AIR LIQUIDE 87
5.1.7.1 Business overview 87
5.1.7.2 Products offered 88
5.1.7.3 Recent developments 89
5.1.7.3.1 Deals 89
5.1.8 FLEXICARE (GROUP) LIMITED 90
5.1.8.1 Business overview 90
5.1.8.2 Products offered 91
5.1.8.3 Recent developments 91
5.1.8.3.1 Deals 91
?
5.1.9 NIHON KOHDEN CORPORATION 92
5.1.9.1 Business overview 92
5.1.9.2 Products offered 93
5.1.9.3 Recent developments 94
5.1.9.3.1 Product launches 94
5.1.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 95
5.1.10.1 Business overview 95
5.1.10.2 Products offered 96
5.1.11 GE HEALTHCARE 97
5.1.11.1 Business overview 97
5.1.11.2 Products offered 98
5.1.11.3 Recent developments 98
5.1.11.3.1 Deals 98
5.1.12 BAXTER 99
5.1.12.1 Business overview 99
5.1.12.2 Products offered 100
5.1.12.3 Recent developments 100
5.1.12.3.1 Deals 100
5.1.13 VYAIRE MEDICAL, INC. 101
5.1.13.1 Business overview 101
5.1.13.2 Products offered 101
5.1.13.3 Recent developments 102
5.1.13.3.1 Deals 102
5.1.13.3.2 Other developments 102
5.1.14 HAMILTON MEDICAL 103
5.1.14.1 Business overview 103
5.1.14.2 Products offered 103
5.1.14.3 Recent developments 103
5.1.14.3.1 Product enhancements 103
5.2 OTHER PLAYERS 104
5.2.1 SKANRAY TECHNOLOGIES, LTD. 104
5.2.2 AXCENT MEDICAL GMBH 105
5.2.3 METRAN CO., LTD. 105
5.2.4 MAGNAMED 106
5.2.5 LEISTUNG INGENIERIA SRL 106
5.2.6 AVASARALA TECHNOLOGIES LIMITED 107
5.2.7 AIRON CORPORATION 107
5.2.8 TRITON ELECTRONIC SYSTEMS LTD. 108
5.2.9 BIO-MED DEVICES, INC. 108
5.2.10 HEYER MEDICAL AG 109
5.2.11 AGVA HEALTHCARE 109
5.2.12 BIODESIGN INNOVATION LABS 110
5.2.13 NOCCARC ROBOTICS PVT LTD 110
5.2.14 UMBULIZER 111
5.2.15 SCHILLER HEALTHCARE INDIA PVT. LTD 111
5.2.16 AVI HEALTHCARE 112
6 APPENDIX 113
6.1 RESEARCH METHODOLOGY 113
6.1.1 RESEARCH DATA 113
6.1.1.1 Secondary research 114
6.1.1.2 Primary research 115
6.1.2 RESEARCH ASSUMPTIONS 117
6.1.3 RESEARCH LIMITATIONS 117
6.1.4 RISK ASSESSMENT 118
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 118
6.3 AUTHOR DETAILS 121
TABLE 1 DISORDERS AND DEATHS CAUSED DUE TO SMOKING, 2024 18
TABLE 2 INDUSTRY TRENDS IN VENTILATORS MARKET 25
TABLE 3 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 34
TABLE 4 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS 36
TABLE 5 LIST OF PATENTS IN VENTILATORS MARKET (2025) 40
TABLE 6 VENTILATORS MARKET: KEY CONFERENCES AND EVENTS, 2023-2024 41
TABLE 7 REIMBURSEMENT SCENARIO IN VENTILATORS MARKET 43
TABLE 8 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
VENTILATORS MARKET, 2021-2025 46
TABLE 9 VENTILATORS MARKET: DEGREE OF COMPETITION 49
TABLE 10 VENTILATORS MARKET: REGION FOOTPRINT 53
TABLE 11 VENTILATORS MARKET: TYPE FOOTPRINT 54
TABLE 12 VENTILATORS MARKET: AGE GROUP FOOTPRINT 55
TABLE 13 VENTILATORS MARKET: INTERFACE FOOTPRINT 56
TABLE 14 VENTILATORS MARKET: MODE FOOTPRINT 57
TABLE 15 VENTILATORS MARKET: CARE SETTING FOOTPRINT 58
TABLE 16 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 61
TABLE 17 VENTILATORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 61
TABLE 18 VENTILATORS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 65
TABLE 19 VENTILATORS MARKET: DEALS, JANUARY 2021-JANUARY 2025 66
TABLE 20 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 67
TABLE 21 RESMED: BUSINESS OVERVIEW 68
TABLE 22 RESMED: PRODUCTS OFFERED 69
TABLE 23 RESMED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025 70
TABLE 24 GETINGE AB: BUSINESS OVERVIEW 71
TABLE 25 GETINGE AB: PRODUCTS OFFERED 72
TABLE 26 GETINGE AB: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025 73
TABLE 27 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 73
TABLE 28 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 75
TABLE 29 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 76
TABLE 30 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 77
TABLE 31 DRAGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 78
TABLE 32 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED 79
TABLE 33 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES,
JANUARY 2021-JANUARY 2025 79
TABLE 34 DRAGERWERK AG & CO. KGAA: DEALS, JANUARY 2021-JANUARY 2025 80
TABLE 35 DRAGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 80
TABLE 36 ICU MEDICAL INC.: BUSINESS OVERVIEW 81
TABLE 37 ICU MEDICAL, INC.: PRODUCTS OFFERED 82
TABLE 38 ICU MEDICAL, INC.: DEALS, JANUARY 2021-JANUARY 2025 83
TABLE 39 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 84
TABLE 40 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 85
TABLE 41 ASAHI KASEI MEDICAL: DEALS, JANUARY 2021-JANUARY 2025 86
TABLE 42 AIR LIQUIDE: BUSINESS OVERVIEW 87
TABLE 43 AIR LIQUIDE: PRODUCTS OFFERED 88
TABLE 44 AIR LIQUIDE: DEALS, JANUARY 2021-JANUARY 2025 89
TABLE 45 FLEXICARE (GROUP) LIMITED: BUSINESS OVERVIEW 90
TABLE 46 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED 91
TABLE 47 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021-JANUARY 2025 91
TABLE 48 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 92
TABLE 49 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 93
TABLE 50 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021-JANUARY 2025 94
TABLE 51 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: BUSINESS OVERVIEW 95
TABLE 52 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 96
TABLE 53 GE HEALTHCARE: BUSINESS OVERVIEW 97
TABLE 54 GE HEALTHCARE: PRODUCTS OFFERED 98
TABLE 55 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025 98
TABLE 56 BAXTER: BUSINESS OVERVIEW 99
TABLE 57 BAXTER: PRODUCTS OFFERED 100
TABLE 58 BAXTER: DEALS, JANUARY 2021-JANUARY 2025 100
TABLE 59 VYAIRE MEDICAL, INC: BUSINESS OVERVIEW 101
TABLE 60 VYAIRE MEDICAL, INC: PRODUCTS OFFERED 101
TABLE 61 VYAIRE MEDICAL, INC: DEALS, JANUARY 2021-JANUARY 2025 102
TABLE 62 VYAIRE MEDICAL, INC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 102
TABLE 63 HAMILTON MEDICAL: BUSINESS OVERVIEW 103
TABLE 64 HAMILTON MEDICAL: PRODUCTS OFFERED 103
TABLE 65 HAMILTON MEDICAL: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025 103
TABLE 66 RISK ASSESSMENT 118
FIGURE 1 VENTILATORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 13
FIGURE 2 VENTILATORS MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 14
FIGURE 3 VENTILATORS MARKET, BY INTERFACE, 2024 VS. 2029 (USD MILLION) 14
FIGURE 4 VENTILATORS MARKET, BY MODE, 2024 VS. 2029 (USD MILLION) 15
FIGURE 5 VENTILATORS MARKET, BY CARE SETTING, 2024 VS. 2029 (USD MILLION) 15
FIGURE 6 GEOGRAPHICAL SNAPSHOT OF VENTILATORS MARKET 16
FIGURE 7 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 17
FIGURE 8 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION,
BY DISEASE TYPE, 2024 19
FIGURE 9 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015-2023 20
FIGURE 10 ACQUISITIONS IN VENTILATORS MARKET, JANUARY 2019-NOVEMBER 2023 26
FIGURE 11 VENTILATORS MARKET: VALUE CHAIN ANALYSIS 32
FIGURE 12 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 33
FIGURE 13 VENTILATORS MARKET: SUPPLY CHAIN ANALYSIS 36
FIGURE 14 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS 37
FIGURE 15 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS),
JANUARY 2015-FEBRUARY 2025 39
FIGURE 16 AI INTEGRATION FOR VENTILATORS 44
FIGURE 17 IMPACT OF AI/GEN AI ON VENTILATORS MARKET 45
FIGURE 18 REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2019-2023) 48
FIGURE 19 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2023) 48
FIGURE 20 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 51
FIGURE 21 VENTILATORS MARKET: COMPANY FOOTPRINT 52
FIGURE 22 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 60
FIGURE 23 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2022 VS. 2023) 62
FIGURE 24 EV/EBITDA OF KEY VENDORS 63
FIGURE 25 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS 63
FIGURE 26 BRAND/PRODUCT COMPARATIVE ANALYSIS 64
FIGURE 27 RESMED: COMPANY SNAPSHOT (2023) 69
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2023) 72
FIGURE 29 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 76
FIGURE 30 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 78
FIGURE 31 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023) 82
FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2023) 85
FIGURE 33 AIR LIQUIDE: COMPANY SNAPSHOT (2023) 88
FIGURE 34 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023) 93
FIGURE 35 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2023) 95
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 98
FIGURE 37 BAXTER: COMPANY SNAPSHOT (2023) 100
FIGURE 38 RESEARCH DESIGN 113
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security